Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: Involvement of pigment epithelium-derived factor

Shu Huei Wang, Shing Jong Lin, Yung Hsiang Chen, Fen Yen Lin, Jin Chung Shih, Chau Chung Wu, Hua Lin Wu, Yuh Lien Chen

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

OBJECTIVES-: The number of endothelial progenitor cells (EPCs) that can be obtained from adult bone marrow and peripheral blood to treat cardiovascular diseases is limited. The goal was to examine the endothelial potential of Wharton jelly in human umbilical cord (WJC)-derived stem cells and evaluate their potential to affect neointimal formation after vascular injury. METHODS AND RESULTS-: Mesenchymal cells (MCs) were isolated from WJC and cultured in endothelial growth medium. Differentiation into late outgrowth endothelial cells (WJC-OECs) was demonstrated by incorporation of acetylated low-density lipoprotein and expression of the endothelial-specific markers. Transplantation of these cells into wire-injured femoral arteries in mice led to rapid reendothelialization. At 4 weeks after injury, the neointima/media area ratio was reduced and strong expression of pigment epithelium-derived factor (PEDF) compared to saline-or MC- or cord blood-OEC-treated mice. WJC-OECs-conditioned medium has an extremely strong capacity to inhibit the migration and proliferation of smooth muscle cells. The effects were inhibited by neutralizing antibody for PEDF and by siRNA silencing of PEDF. CONCLUSIONS-: We firstly demonstrated the presence of a cell population within WJC that has the potential to differentiate into OECs. Transplantation of WJC-OECs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia. These findings have implications for a novel and practical cell-based therapy for vascular diseases.

Original languageEnglish
Pages (from-to)816-822
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 2009

Fingerprint

Wharton Jelly
Umbilical Cord
Vascular System Injuries
Endothelial Cells
Neointima
Cell Transplantation
Femoral Artery
Conditioned Culture Medium
Cell- and Tissue-Based Therapy
Neutralizing Antibodies
Fetal Blood
Vascular Diseases
Small Interfering RNA
Smooth Muscle Myocytes
Hyperplasia
Cardiovascular Diseases
Stem Cells
Transplantation
Bone Marrow
Wounds and Injuries

Keywords

  • Cell therapy
  • Endothelial progenitor cells
  • Pigment epithelium-derived factor
  • Restenosis
  • Wharton jelly

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury : Involvement of pigment epithelium-derived factor. / Wang, Shu Huei; Lin, Shing Jong; Chen, Yung Hsiang; Lin, Fen Yen; Shih, Jin Chung; Wu, Chau Chung; Wu, Hua Lin; Chen, Yuh Lien.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 29, No. 6, 06.2009, p. 816-822.

Research output: Contribution to journalArticle

@article{1ed6a6fb55d1430199576856ebfdfc8c,
title = "Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: Involvement of pigment epithelium-derived factor",
abstract = "OBJECTIVES-: The number of endothelial progenitor cells (EPCs) that can be obtained from adult bone marrow and peripheral blood to treat cardiovascular diseases is limited. The goal was to examine the endothelial potential of Wharton jelly in human umbilical cord (WJC)-derived stem cells and evaluate their potential to affect neointimal formation after vascular injury. METHODS AND RESULTS-: Mesenchymal cells (MCs) were isolated from WJC and cultured in endothelial growth medium. Differentiation into late outgrowth endothelial cells (WJC-OECs) was demonstrated by incorporation of acetylated low-density lipoprotein and expression of the endothelial-specific markers. Transplantation of these cells into wire-injured femoral arteries in mice led to rapid reendothelialization. At 4 weeks after injury, the neointima/media area ratio was reduced and strong expression of pigment epithelium-derived factor (PEDF) compared to saline-or MC- or cord blood-OEC-treated mice. WJC-OECs-conditioned medium has an extremely strong capacity to inhibit the migration and proliferation of smooth muscle cells. The effects were inhibited by neutralizing antibody for PEDF and by siRNA silencing of PEDF. CONCLUSIONS-: We firstly demonstrated the presence of a cell population within WJC that has the potential to differentiate into OECs. Transplantation of WJC-OECs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia. These findings have implications for a novel and practical cell-based therapy for vascular diseases.",
keywords = "Cell therapy, Endothelial progenitor cells, Pigment epithelium-derived factor, Restenosis, Wharton jelly",
author = "Wang, {Shu Huei} and Lin, {Shing Jong} and Chen, {Yung Hsiang} and Lin, {Fen Yen} and Shih, {Jin Chung} and Wu, {Chau Chung} and Wu, {Hua Lin} and Chen, {Yuh Lien}",
year = "2009",
month = "6",
doi = "10.1161/ATVBAHA.109.184739",
language = "English",
volume = "29",
pages = "816--822",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury

T2 - Involvement of pigment epithelium-derived factor

AU - Wang, Shu Huei

AU - Lin, Shing Jong

AU - Chen, Yung Hsiang

AU - Lin, Fen Yen

AU - Shih, Jin Chung

AU - Wu, Chau Chung

AU - Wu, Hua Lin

AU - Chen, Yuh Lien

PY - 2009/6

Y1 - 2009/6

N2 - OBJECTIVES-: The number of endothelial progenitor cells (EPCs) that can be obtained from adult bone marrow and peripheral blood to treat cardiovascular diseases is limited. The goal was to examine the endothelial potential of Wharton jelly in human umbilical cord (WJC)-derived stem cells and evaluate their potential to affect neointimal formation after vascular injury. METHODS AND RESULTS-: Mesenchymal cells (MCs) were isolated from WJC and cultured in endothelial growth medium. Differentiation into late outgrowth endothelial cells (WJC-OECs) was demonstrated by incorporation of acetylated low-density lipoprotein and expression of the endothelial-specific markers. Transplantation of these cells into wire-injured femoral arteries in mice led to rapid reendothelialization. At 4 weeks after injury, the neointima/media area ratio was reduced and strong expression of pigment epithelium-derived factor (PEDF) compared to saline-or MC- or cord blood-OEC-treated mice. WJC-OECs-conditioned medium has an extremely strong capacity to inhibit the migration and proliferation of smooth muscle cells. The effects were inhibited by neutralizing antibody for PEDF and by siRNA silencing of PEDF. CONCLUSIONS-: We firstly demonstrated the presence of a cell population within WJC that has the potential to differentiate into OECs. Transplantation of WJC-OECs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia. These findings have implications for a novel and practical cell-based therapy for vascular diseases.

AB - OBJECTIVES-: The number of endothelial progenitor cells (EPCs) that can be obtained from adult bone marrow and peripheral blood to treat cardiovascular diseases is limited. The goal was to examine the endothelial potential of Wharton jelly in human umbilical cord (WJC)-derived stem cells and evaluate their potential to affect neointimal formation after vascular injury. METHODS AND RESULTS-: Mesenchymal cells (MCs) were isolated from WJC and cultured in endothelial growth medium. Differentiation into late outgrowth endothelial cells (WJC-OECs) was demonstrated by incorporation of acetylated low-density lipoprotein and expression of the endothelial-specific markers. Transplantation of these cells into wire-injured femoral arteries in mice led to rapid reendothelialization. At 4 weeks after injury, the neointima/media area ratio was reduced and strong expression of pigment epithelium-derived factor (PEDF) compared to saline-or MC- or cord blood-OEC-treated mice. WJC-OECs-conditioned medium has an extremely strong capacity to inhibit the migration and proliferation of smooth muscle cells. The effects were inhibited by neutralizing antibody for PEDF and by siRNA silencing of PEDF. CONCLUSIONS-: We firstly demonstrated the presence of a cell population within WJC that has the potential to differentiate into OECs. Transplantation of WJC-OECs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia. These findings have implications for a novel and practical cell-based therapy for vascular diseases.

KW - Cell therapy

KW - Endothelial progenitor cells

KW - Pigment epithelium-derived factor

KW - Restenosis

KW - Wharton jelly

UR - http://www.scopus.com/inward/record.url?scp=66349089605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66349089605&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.109.184739

DO - 10.1161/ATVBAHA.109.184739

M3 - Article

C2 - 19342598

AN - SCOPUS:66349089605

VL - 29

SP - 816

EP - 822

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 6

ER -